Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Rogaratinib (BAY1163877)_Overall Population	87
Overall Study	STARTED	Chemotherapy_Overall Population	88
Overall Study	Started Treatment	Rogaratinib (BAY1163877)_Overall Population	86
Overall Study	Started Treatment	Chemotherapy_Overall Population	82
Overall Study	Active Follow-up Performed	Rogaratinib (BAY1163877)_Overall Population	61
Overall Study	Active Follow-up Performed	Chemotherapy_Overall Population	56
Overall Study	Entered Long Term Follow-up	Rogaratinib (BAY1163877)_Overall Population	56
Overall Study	Entered Long Term Follow-up	Chemotherapy_Overall Population	69
Overall Study	COMPLETED	Rogaratinib (BAY1163877)_Overall Population	0
Overall Study	COMPLETED	Chemotherapy_Overall Population	0
Overall Study	NOT COMPLETED	Rogaratinib (BAY1163877)_Overall Population	87
Overall Study	NOT COMPLETED	Chemotherapy_Overall Population	88

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03410693/flow